In a clinical trial, the correction of prolactin levels in male patients with severe hyperprolactinemia using medications such as cabergoline (CAB) or bromocriptine (BRC) improved hypogonadism-related symptoms [4]. The gene discussed is PRL; the disease is hyperprolactinemia.